Favicon
Favicon

A New Look for the Ragon Institute

Date: February 9, 2023 By: Emily Makowski

Collaborate. Research. Cure. These three words embody the spirit of what we represent at the Ragon Institute of Mass General, MIT, and Harvard.

We’re proud to announce our new logo — and tagline — as part of an institute-wide rebrand ahead of the opening of our new building next year!

Our updated visual identity combines elements of unity, collaboration, and clarity to create an intelligent framework for conveying our mission and vision. It demonstrates the Institute’s continued connection to the brilliant teams and individuals at Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, and also represents our boldness in targeting the most intractable diseases — such as HIV, tuberculosis, and malaria — with the power of cutting-edge scientific research.

While the look and feel of our brand may be different moving forward, the Ragon Institute is more committed than ever to realizing our goals of leveraging cross-disciplinary collaboration to transform human health on a global scale; developing and deploying novel scientific research to improve health and care outcomes; and harnessing the immune system to prevent and cure human disease.

Join us in celebrating the launch of our new brand as we look forward to a more innovative and successful future. Together, we can work to overcome the toughest health challenges facing our world today.

More News

Press Releases

Ringel Lab Study Reveals Age-Related Decline in Tumor-Fighting T Cells and Its Impact on Cancer Treatment

Researchers at the Ragon Institute of Mass General Brigham, MIT, and Harvard have uncovered critical insights into how aging impairs the immune system’s ability to fight cancer.

Press Releases

New Research from the Ragon and Broad Unveils the Protective Role of CD4+ T Cells in Tuberculosis Reinfection

This study, published in Immunity on August 30, used a non-human primate model to demonstrate that previous Mtb infection leads to a durable, protective immune response that is dependent on CD4+ T cells.

Press Releases

MIT News – A two-dose schedule could make HIV vaccines more effective

MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.